US 11191774
Drug formulations for cancer treatment
granted A61KA61K31/505A61K31/506
Quick answer
US patent 11191774 (Drug formulations for cancer treatment) held by The Regents of the University of California expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/513, A61K31/70